fluorouracil has been researched along with Adenocarcinoma, Scirrhous in 39 studies
Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.
Adenocarcinoma, Scirrhous: An adenocarcinoma with a hard (Greek skirrhos, hard) structure owing to the formation of dense connective tissue in the stroma. (From Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Uterine metastases of the breast cancer caused obstructive nephropathy." | 5.35 | [A case of stage IV breast cancer with large cancer ulcer responding to combination therapy of capecitabine and medroxyprogesterone acetate and cyclophosphamide]. ( Hasegawa, N; Iimura, Y; Kaneko, H; Kawabata, M; Konishi, K; Shoji, Y, 2009) |
| " A phase II study of sequential high-dose methotrexate and fluorouracil, combined with doxorubicin, as a neoadjuvant chemotherapy was conducted in an attempt to evaluate the efficacy of this regimen in improving the survival of patients with scirrhous gastric cancer." | 2.70 | Phase II study of sequential high-dose methotrexate and fluorouracil combined with doxorubicin as a neoadjuvant chemotherapy for scirrhous gastric cancer. ( Boku, N; Inoue, K; Kinoshita, T; Konishi, M; Nakagouri, T; Ohtsu, A; Ono, M; Sugitou, M; Takahashi, S; Yoshida, S, 2001) |
| "Therapies for patients with scirrhous gastric cancer remain ineffective." | 1.46 | Effects of 5-fluorouracil, adriamycin and irinotecan on HSC-39, a human scirrhous gastric cancer cell line. ( Amano, F; Kanai-Mori, A; Koike, A; Morishige, Y; Tamaki, R; Yanagihara, K, 2017) |
| "The HER2-positive rate of gastric cancer tends to be high for a well-differentiated adenocarcinoma." | 1.38 | [A complete response of scirrhous gastric carcinoma treated with trastuzumab combination therapy]. ( Hamamoto, Y; Nishi, T; Onodera, K; Uemoto, J; Warita, E; Yamanaka, Y, 2012) |
| "This patient with advanced breast cancer accompanied by distant metastasis responded to trastuzumab/docetaxel combination therapy." | 1.36 | [Efficacy of FEC and trastuzumab/docetaxel combination therapy for metastatic breast cancer]. ( Kanzaki, M; Maeda, M; Matsumoto, K; Miyoshi, S; Takano, Y; Teshima, S; Wakita, T; Yoshinouchi, S, 2010) |
| "Uterine metastases of the breast cancer caused obstructive nephropathy." | 1.35 | [A case of stage IV breast cancer with large cancer ulcer responding to combination therapy of capecitabine and medroxyprogesterone acetate and cyclophosphamide]. ( Hasegawa, N; Iimura, Y; Kaneko, H; Kawabata, M; Konishi, K; Shoji, Y, 2009) |
| " The pan-caspase inhibitor, zVAD-fmk, inhibits apoptosis induced in combination with 5FU and mTOR inhibitor." | 1.35 | Synergistic antiproliferative effect of mTOR inhibitors in combination with 5-fluorouracil in scirrhous gastric cancer. ( Doi, Y; Hirakawa, K; Kaizaki, R; Matsuzaki, T; Ohira, M; Sawada, T; Yashiro, M; Yasuda, K, 2009) |
| "Paclitaxel also has a high response rate for undifferentiated-type adenocarcinoma, and can be expected to show high efficacy for peritoneal dissemination." | 1.34 | [Therapeutic strategy for type 4 gastric cancer from the clinical oncologist standpoint]. ( Ae, T; Higuchi, K; Ishido, K; Katada, C; Koizumi, W; Nakatani, K; Saigenji, K; Sasaki, T; Tanabe, S, 2007) |
| "It seems that the quality of life for breast cancer patients was affected by the extent of the alopecia." | 1.33 | [A case of advanced breast cancer markedly responding to chemo-endocrine therapy with only slight alopecia]. ( Iwakuma, N; Nagamatsu, H; Ono, H; Shirouzu, K; Terazaki, Y, 2005) |
| "The human scirrhous gastric cancer cell lines OCUM-2D or OCUM-2M, and human gastric fibroblasts (NF-21) were cultured in the absence or presence of JTE-522 at various concentrations." | 1.33 | Inhibitory effect of a selective cyclooxygenase inhibitor on the invasion-stimulating activity of orthotopic fibroblasts for scirrhous gastric cancer cells. ( Hirakawa, K; Nakazawa, K; Tendo, M; Yamada, N; Yashiro, M, 2005) |
| "We report a case of breast cancer with spinal and vertebral lesions." | 1.32 | [Successful combination therapy with 5'-DFUR and MPA for breast cancer with spinal and vertebral metastases]. ( Hashiguchi, H; Hirooka, Y; Kamasako, A; Nozaka, K; Ohgami, Y; Otani, S; Takebayashi, M; Tanida, O; Toyota, N; Wakatsuki, T, 2004) |
| "Higher TP expression was observed in ovarian cancers than in normal ovaries." | 1.32 | [Significance of tissue thymidine phosphorylase and dihydropyrimidine dehydrogenase activities in ovarian cancer]. ( Akimoto, T; Hasegawa, K; Kishimoto, Y; Morimoto, Y; Sawai, T, 2004) |
| "Since metastases to the liver, left adrenal gland, and Douglas' pouch were detected in addition to ascites and bilateral hydronephrosis, the tumor was judged unresectable and systemic chemotherapy with TS-1 was begun." | 1.31 | [A case in which TS-1, an orally-administered 5-FU chemotherapeutic agent, showed marked effectiveness against scirrhous type gastric cancer with multiple organ metastases]. ( Araki, S; Asakura, R; Itou, A; Kobayashi, K; Naganuma, J; Teruya, M; Yanagida, O, 2002) |
| "An advanced gastric cancer patient with multiple retroperitoneal lymph node metastases and bone metastases was treated with sequential MTX and 5-FU." | 1.29 | [A case of nonresectable gastric cancer treated by sequential methotrexate and 5-fluorouracil]. ( Anai, H; Furuyama, M; Ikejiri, K; Maekawa, S; Muranaka, T; Saku, M; Takeo, S; Yakabe, S, 1994) |
| "Investigations were made on 76 cases of scirrhous carcinoma of the stomach in the care of our department, and the treatment methods in these cases were as follows: 1) Lymph node dissection: Lymphadenectomy of over R2 is performed." | 1.27 | [Treatment methods for scirrhous carcinoma of the stomach--with special reference to total gastrectomy and chemotherapy in early postoperative period]. ( Hamakubo, S; Higashino, K; Nabeya, K; Nyumura, T, 1988) |
| "A group of patients with metastatic breast cancer treated by a distinct drug regimen is analyzed with special respect to clinical and psychological problems." | 1.26 | [Experiences with drug therapy of advanced metastatic carcinoma of the breast (author's transl)]. ( Fernholz, HJ; Frik, W; Nüvemann, M, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (41.03) | 18.7374 |
| 1990's | 2 (5.13) | 18.2507 |
| 2000's | 13 (33.33) | 29.6817 |
| 2010's | 8 (20.51) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tamaki, R | 1 |
| Kanai-Mori, A | 1 |
| Morishige, Y | 1 |
| Koike, A | 1 |
| Yanagihara, K | 1 |
| Amano, F | 1 |
| Kimura, M | 1 |
| Tominaga, T | 1 |
| Takatsuka, Y | 1 |
| Toi, M | 1 |
| Abe, R | 1 |
| Koyama, H | 1 |
| Takashima, S | 1 |
| Nomura, Y | 1 |
| Miura, S | 1 |
| Kimijima, I | 1 |
| Tashiro, H | 1 |
| Ohashi, Y | 1 |
| Yashiro, M | 3 |
| Shinto, O | 1 |
| Nakamura, K | 1 |
| Tendo, M | 2 |
| Matsuoka, T | 1 |
| Matsuzaki, T | 2 |
| Kaizaki, R | 2 |
| Miwa, A | 1 |
| Hirakawa, K | 3 |
| Konishi, K | 1 |
| Hasegawa, N | 1 |
| Kaneko, H | 1 |
| Iimura, Y | 1 |
| Shoji, Y | 1 |
| Kawabata, M | 1 |
| Yasuda, K | 1 |
| Doi, Y | 1 |
| Sawada, T | 1 |
| Ohira, M | 1 |
| Matsumoto, K | 1 |
| Yoshinouchi, S | 1 |
| Takano, Y | 1 |
| Kanzaki, M | 1 |
| Maeda, M | 1 |
| Miyoshi, S | 1 |
| Wakita, T | 1 |
| Teshima, S | 1 |
| Ide, Y | 1 |
| Ito, Y | 1 |
| Takahashi, S | 2 |
| Tokudome, N | 1 |
| Kobayashi, K | 2 |
| Sugihara, T | 1 |
| Hattori, M | 1 |
| Yokoyama, M | 1 |
| Uchiyama, A | 1 |
| Inoue, K | 2 |
| Sakurai, N | 1 |
| Hatake, K | 1 |
| Nakamura, Y | 1 |
| Aono, T | 1 |
| Nomura, M | 1 |
| Iwase, K | 1 |
| Tanaka, Y | 1 |
| Nishi, T | 1 |
| Hamamoto, Y | 1 |
| Uemoto, J | 1 |
| Onodera, K | 1 |
| Warita, E | 1 |
| Yamanaka, Y | 1 |
| Yamauchi, S | 1 |
| Nakagawa, T | 1 |
| Kasahara, M | 1 |
| Sugimoto, H | 1 |
| Ishiba, T | 1 |
| Tamura, N | 1 |
| Nagahara, M | 1 |
| Sato, T | 1 |
| Sugihara, K | 1 |
| HELSPER, JT | 1 |
| DEMOSS, EV | 1 |
| Otani, S | 1 |
| Toyota, N | 1 |
| Nozaka, K | 1 |
| Wakatsuki, T | 1 |
| Takebayashi, M | 1 |
| Kamasako, A | 1 |
| Tanida, O | 1 |
| Hashiguchi, H | 1 |
| Ohgami, Y | 1 |
| Hirooka, Y | 1 |
| Morimoto, Y | 1 |
| Hasegawa, K | 1 |
| Sawai, T | 1 |
| Kishimoto, Y | 1 |
| Akimoto, T | 1 |
| Terazaki, Y | 1 |
| Nagamatsu, H | 1 |
| Ono, H | 1 |
| Iwakuma, N | 1 |
| Shirouzu, K | 1 |
| Nakazawa, K | 1 |
| Yamada, N | 1 |
| Mimae, T | 1 |
| Ninomiya, M | 2 |
| Sasaki, H | 2 |
| Kubo, Y | 1 |
| Kojima, T | 1 |
| Umeoka, T | 2 |
| Takakura, N | 2 |
| Satoh, D | 1 |
| Harano, M | 1 |
| Aoki, H | 1 |
| Onoda, T | 1 |
| Shiozaki, Y | 1 |
| Ohno, S | 1 |
| Higaki, K | 1 |
| Sasaki, T | 1 |
| Koizumi, W | 1 |
| Higuchi, K | 1 |
| Ishido, K | 1 |
| Ae, T | 1 |
| Nakatani, K | 1 |
| Katada, C | 1 |
| Tanabe, S | 2 |
| Saigenji, K | 1 |
| Wakui, A | 1 |
| Anai, H | 1 |
| Muranaka, T | 1 |
| Takeo, S | 1 |
| Maekawa, S | 1 |
| Ikejiri, K | 1 |
| Yakabe, S | 1 |
| Furuyama, M | 1 |
| Saku, M | 1 |
| Gochi, A | 1 |
| Murashima, N | 1 |
| Gotoh, K | 1 |
| Matsuno, T | 1 |
| Matsuoka, J | 1 |
| Tanaka, N | 1 |
| Orita, K | 1 |
| Kinoshita, T | 1 |
| Konishi, M | 1 |
| Nakagouri, T | 1 |
| Ono, M | 1 |
| Sugitou, M | 1 |
| Ohtsu, A | 1 |
| Boku, N | 1 |
| Yoshida, S | 1 |
| Tsuchiya, K | 1 |
| Takemura, N | 1 |
| Nakano, K | 1 |
| Osaka, Y | 1 |
| Sako, H | 1 |
| Ioka, Z | 1 |
| Nakane, Y | 1 |
| Yanagida, O | 1 |
| Teruya, M | 1 |
| Itou, A | 1 |
| Naganuma, J | 1 |
| Asakura, R | 1 |
| Araki, S | 1 |
| Shiian, DN | 2 |
| Otto, R | 1 |
| Zwicker, H | 1 |
| Engeler, V | 1 |
| Nüvemann, M | 1 |
| Fernholz, HJ | 1 |
| Frik, W | 1 |
| Koike, H | 1 |
| Konishi, T | 1 |
| Mafune, K | 1 |
| Hirata, T | 1 |
| Miyama, T | 1 |
| Hiraishi, M | 1 |
| Idezuki, Y | 1 |
| Nyumura, T | 1 |
| Nabeya, K | 1 |
| Hamakubo, S | 1 |
| Higashino, K | 1 |
| Akazawa, S | 1 |
| Yoshida, K | 1 |
| Izumi, T | 1 |
| Sasaki, J | 1 |
| Ito, T | 1 |
| Kurihara, M | 1 |
| Suga, S | 1 |
| Horiuchi, Y | 1 |
| Ohkita, T | 1 |
| Shimaji, T | 1 |
| Goto, S | 1 |
| Yokoyama, Y | 1 |
| Nagayo, T | 1 |
| Okawa, T | 1 |
| Ikeda, M | 1 |
| Mikuriya, S | 1 |
| Hashimoto, S | 1 |
| Amino, S | 1 |
| Horiuchi, J | 1 |
| Matsuda, T | 1 |
| Ebata, K | 1 |
| Kaneda, K | 1 |
| Starichkov, MS | 1 |
| Sorokina, EA | 1 |
| Navashin, SM | 1 |
| Fomina, IP | 1 |
| Osokina, LI | 1 |
| Zharikov, AA | 1 |
| Martorelli, B | 1 |
| Alberto, P | 1 |
| Gründer, K | 1 |
| Leyh, F | 1 |
| Gnatyshak, AI | 1 |
2 reviews available for fluorouracil and Adenocarcinoma, Scirrhous
| Article | Year |
|---|---|
[A case of metastatic breast cancer with bilateral hydronephrosis effectively treated with capecitabine].
Topics: Adenocarcinoma, Scirrhous; Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Deoxycyt | 2012 |
[Chemotherapy of scirrhous gastric cancer].
Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; E | 1994 |
2 trials available for fluorouracil and Adenocarcinoma, Scirrhous
| Article | Year |
|---|---|
Randomized trial of cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil with node-positive breast cancer in Japan.
Topics: Adenocarcinoma; Adenocarcinoma, Scirrhous; Adult; Antineoplastic Combined Chemotherapy Protocols; Ax | 2010 |
Phase II study of sequential high-dose methotrexate and fluorouracil combined with doxorubicin as a neoadjuvant chemotherapy for scirrhous gastric cancer.
Topics: Adenocarcinoma, Scirrhous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; | 2001 |
35 other studies available for fluorouracil and Adenocarcinoma, Scirrhous
| Article | Year |
|---|---|
Effects of 5-fluorouracil, adriamycin and irinotecan on HSC-39, a human scirrhous gastric cancer cell line.
Topics: Adenocarcinoma, Scirrhous; Apoptosis; Camptothecin; Cell Line; Cell Proliferation; Cell Survival; Do | 2017 |
Synergistic antitumor effects of FGFR2 inhibitor with 5-fluorouracil on scirrhous gastric carcinoma.
Topics: Adenocarcinoma, Scirrhous; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineop | 2010 |
[A case of stage IV breast cancer with large cancer ulcer responding to combination therapy of capecitabine and medroxyprogesterone acetate and cyclophosphamide].
Topics: Adenocarcinoma, Scirrhous; Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Age | 2009 |
Synergistic antiproliferative effect of mTOR inhibitors in combination with 5-fluorouracil in scirrhous gastric cancer.
Topics: Adenocarcinoma, Scirrhous; Amino Acid Chloromethyl Ketones; Animals; Antineoplastic Combined Chemoth | 2009 |
[Efficacy of FEC and trastuzumab/docetaxel combination therapy for metastatic breast cancer].
Topics: Adenocarcinoma, Scirrhous; Adult; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, M | 2010 |
Hepatitis B virus reactivation in adjuvant chemotherapy for breast cancer.
Topics: Adenocarcinoma, Scirrhous; Aged; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; B | 2013 |
[Two cases of HER2-positive advanced or metastatic breast cancer, responding to lapatinib and capecitabine].
Topics: Adenocarcinoma, Scirrhous; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplas | 2010 |
[A complete response of scirrhous gastric carcinoma treated with trastuzumab combination therapy].
Topics: Adenocarcinoma, Scirrhous; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy P | 2012 |
REGIONAL INTRA-ARTERIAL INFUSION OF 5-FLUOROURACIL FOR CANCER.
Topics: Adenocarcinoma; Adenocarcinoma, Scirrhous; Carcinoma, Squamous Cell; Female; Fluorouracil; Glioblast | 1964 |
[Successful combination therapy with 5'-DFUR and MPA for breast cancer with spinal and vertebral metastases].
Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combine | 2004 |
[Significance of tissue thymidine phosphorylase and dihydropyrimidine dehydrogenase activities in ovarian cancer].
Topics: 5'-Nucleotidase; Adenocarcinoma, Scirrhous; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineo | 2004 |
[A case of advanced breast cancer markedly responding to chemo-endocrine therapy with only slight alopecia].
Topics: Adenocarcinoma, Scirrhous; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasm | 2005 |
Inhibitory effect of a selective cyclooxygenase inhibitor on the invasion-stimulating activity of orthotopic fibroblasts for scirrhous gastric cancer cells.
Topics: Adenocarcinoma, Scirrhous; Animals; Antineoplastic Agents; Benzenesulfonates; Cell Line, Tumor; Cycl | 2005 |
[A case of recurrent gastric cancer with improvement of obstructive symptoms caused by carcinomatous peritonitis and prolonged survival by chemotherapy with combined use of Paclitaxel and 5-FU].
Topics: Adenocarcinoma, Scirrhous; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality | 2006 |
[A case of progressive gastric carcinoma accompanied by disseminated carcinomatosis of bone marrow due to bone metastasis with DIC recovery by joint administration of 5-FU and paclitaxel].
Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Bo | 2006 |
[Therapeutic strategy for type 4 gastric cancer from the clinical oncologist standpoint].
Topics: Adenocarcinoma, Scirrhous; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phyt | 2007 |
[A case of nonresectable gastric cancer treated by sequential methotrexate and 5-fluorouracil].
Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Drug Admi | 1994 |
[A case of nonresectable scirrhous type gastric cancer successfully treated by low-dose cisplatin (CDDP), 5-fluorouracil (5-FU) and pirarubicin (THP)].
Topics: Adenocarcinoma, Scirrhous; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorub | 2000 |
[A case of gastric cancer with paraaortic lymph node metastasis responding to preoperative chemotherapy and surviving 4 years and 4 months after total gastrectomy].
Topics: Adenocarcinoma, Scirrhous; Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Cisplatin; D | 2002 |
[A case in which TS-1, an orally-administered 5-FU chemotherapeutic agent, showed marked effectiveness against scirrhous type gastric cancer with multiple organ metastases].
Topics: Adenocarcinoma, Scirrhous; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocol | 2002 |
[Determination of individual sensitivity of gastric cancer to 5-fluorouracil by tumor tissue respiratory and glycolytic indices].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adenocarcinoma, Scirrhous; Carcinoma; Fluorouracil; Glycol | 1975 |
[Chemotherapy of breast cancer].
Topics: Adenocarcinoma, Scirrhous; Breast Neoplasms; Calcinosis; Cyclophosphamide; Drug Therapy, Combination | 1976 |
[Experiences with drug therapy of advanced metastatic carcinoma of the breast (author's transl)].
Topics: Adenocarcinoma; Adenocarcinoma, Scirrhous; Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Car | 1976 |
[Effect of sequential MTX/5-FU therapy for a case of disseminated intravascular coagulation syndrome associated with recurrence of gastric cancer--a case report].
Topics: Adenocarcinoma, Scirrhous; Adult; Disseminated Intravascular Coagulation; Fluorouracil; Humans; Male | 1989 |
[Treatment methods for scirrhous carcinoma of the stomach--with special reference to total gastrectomy and chemotherapy in early postoperative period].
Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Fluorouracil; | 1988 |
[The role of thymidylate synthetase in sequential dose of MTX and 5-FU in the advanced scirrhous type gastric cancer].
Topics: Adenocarcinoma, Scirrhous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Adminis | 1988 |
[Cancer chemotherapy of scirrhous type gastric cancer and evaluation of chemotherapeutic efficacy].
Topics: Adenocarcinoma, Scirrhous; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Cyt | 1988 |
[Therapeutic treatment of Borrmann type 4 (scirrhous) gastric cancer-chemotherapy and histopathological studies].
Topics: Adenocarcinoma, Scirrhous; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration | 1988 |
[A clinical study of radiotherapy with HCFU for advanced and recurrent breast cancers. Radiation and HCFU Study Group for breast cancer].
Topics: Adenocarcinoma, Scirrhous; Adult; Aged; Breast Neoplasms; Carcinoma; Combined Modality Therapy; Eval | 1985 |
[Combined treatment of patients with inoperable stomach cancer].
Topics: Adenocarcinoma; Adenocarcinoma, Scirrhous; Adult; Aged; Carcinoma, Squamous Cell; Female; Fluorourac | 1970 |
[Study of the action of antitumor compounds on primary explants from human tumors].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adenocarcinoma, Scirrhous; Antibiotics, Antineoplastic; An | 1967 |
Effects of chemotherapeutic agents on two lines of human breast carcinomas in tissue culture.
Topics: Adenocarcinoma, Scirrhous; Breast Neoplasms; Culture Techniques; Fluorouracil; Humans; Methotrexate; | 1969 |
[Comments on the treatment of solid tumors with 5-fluorouracil].
Topics: Adenocarcinoma, Scirrhous; Adult; Breast Neoplasms; Carcinoma, Hepatocellular; Female; Fluorouracil; | 1969 |
[Local treatment of skin neoplasms with 5 per cent fluorouracil ointment (report of 6 cases)].
Topics: Adenocarcinoma, Scirrhous; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Fluorourac | 1972 |
[Determination of the individual sensitivity of gastric cancerous tumors to 5-fluorouracil according to respiratory and glycolytic indices].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adenocarcinoma, Scirrhous; Carcinoma; Drug Evaluation, Pre | 1974 |